Skip to main content
BDRX logo

BDRX

Compare

Biodexa Pharmaceuticals Plc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
Values in USD · ADR · Reports in GBP

Historical stock prices for MLP & Strategic Equity Fund Inc. (MTP). MLP & Strategic Equity Fund Inc. (the Fund) is a closed-end management investment company. The Fund's investment objective is to provide a high level of after-tax total return. The Fund pursues its investment objective by investing substantially all of its net assets in publicly traded master limited partnerships (MLPs) operating in the energy infrastructure sector of the market. The Fund may purchase both domestic and international MLPs. The Fund's investment in MLPs may include ownership of MLP common units and MLP subordinated units. The Company invests in industries include oil and gas storage, oil gas explore, coal-consumfuel, gas utilities and oil gas refine. The Fund also may purchase MLP I-Shares (together with the MLPs, the MLP Entities). Nuveen Fund Advisors, Inc. is the Fund's advisor. On August 27, 2012, the Company merged with Nuveen Energy MLP Total Return Fund.

Current Price

Profile
Valuation (TTM)
Market Cap
P/E
EV
P/B
Shares Out
P/Sales
Revenue
EV/EBITDA

Biodexa Pharmaceuticals Plc (BDRX) Valuation

BDRX Valuation Metrics

FCF
FCF Growth Rate
EPS Growth (CAGR)
WACC10.00%

BDRX Valuation & Fair Value Analysis

Biodexa Pharmaceuticals Plc (BDRX) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.

GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of Biodexa Pharmaceuticals Plc's intrinsic value.